Digital Pathology & IHC Biomarker Analysis

From tissue to quantified data: automated staining, high-throughput imaging, and AI-assisted analysis for your preclinical oncology studies. 

Understand your drug’s mechanism and effect faster. Crown Bioscience’s digital pathology platform combines automated IHC and immunofluorescence staining, high-throughput slide scanning, and HALO image analysis to turn tissue into objective, reproducible biomarker data. With 400+ validated IHC markers and multiplex panels, deep immuno-oncology expertise, and the option to pair results with our translational tumor models, you get insight into the tumor microenvironment and treatment response in one workflow. 

Find your IHC target in seconds.
Search our menu of 400+ validated IHC markers (and growing) by category, species, and staining platform. Don’t see your target? Our labs can validate it - contact us today.

• Accelerate your research with our selection of over 400 IHC validated markers and multiplex panels for fast and accurate analysis.
• Streamline your workflow with our integrated digital pathology platform, offering:
  
  • Automated staining with Leica BOND RX and Roche Ventana BenchMark ULTRA.
  • High-throughput imaging via Akoya Biosciences’ PhenoImager® HT and 3DHISTECH Pannoramic Scan.
  • Detailed tissue analysis with the HALO^® image analysis platform, featuring real-time data sharing and remote review capabilities with HALO Link.
• Count on our thorough validation and QC process for consistent and reliable data.
• Draw on our immunology and immuno-oncology expertise using translational tumor models based biomarker analysis to gain insights into the tumor microenvironment and the efficacy of cancer treatments.
• Investigate tumor biology with our Tumor Tissue Microarray (TMA) collection, including a variety of tumor models, commercially available biospecimens, and an extensive FFPE and frozen tissue bank.